Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
$49.38 - $63.75 $3 Million - $3.87 Million
60,694 New
60,694 $3.78 Million
Q4 2022

Jan 25, 2023

SELL
$59.56 - $76.6 $1.61 Million - $2.07 Million
-27,053 Reduced 31.7%
58,282 $0
Q3 2022

Oct 24, 2022

BUY
$57.96 - $78.12 $807,324 - $1.09 Million
13,929 Added 19.51%
85,335 $6.01 Million
Q2 2022

Aug 01, 2022

BUY
$39.5 - $64.42 $121,107 - $197,511
3,066 Added 4.49%
71,406 $4.05 Million
Q1 2022

May 03, 2022

BUY
$43.74 - $62.76 $2.55 Million - $3.66 Million
58,393 Added 587.04%
68,340 $4.28 Million
Q4 2021

Feb 01, 2022

SELL
$50.01 - $73.35 $6.41 Million - $9.4 Million
-128,189 Reduced 92.8%
9,947 $557,000
Q3 2021

Oct 26, 2021

BUY
$59.21 - $78.66 $957,011 - $1.27 Million
16,163 Added 13.25%
138,136 $8.99 Million
Q2 2021

Jul 22, 2021

SELL
$51.39 - $66.9 $319,440 - $415,850
-6,216 Reduced 4.85%
121,973 $7.73 Million
Q1 2021

Apr 12, 2021

BUY
$49.14 - $59.89 $1.8 Million - $2.2 Million
36,654 Added 40.04%
128,189 $7.68 Million
Q4 2020

Jan 27, 2021

SELL
$42.19 - $51.5 $3.36 Million - $4.1 Million
-79,600 Reduced 46.51%
91,535 $4.57 Million
Q3 2020

Oct 26, 2020

BUY
$35.33 - $51.04 $1.67 Million - $2.41 Million
47,204 Added 38.09%
171,135 $8.74 Million
Q2 2020

Jul 27, 2020

BUY
$22.91 - $39.83 $1.72 Million - $2.99 Million
75,175 Added 154.19%
123,931 $4.35 Million
Q1 2020

Apr 28, 2020

BUY
$16.44 - $37.73 $801,548 - $1.84 Million
48,756 New
48,756 $1.24 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.